Extended Data Table 7.
Hypoglycaemia by hypothesised drug/strata combinations. Proportions experiencing hypoglycaemia for each of the hypothesised drug/strata combinations.
| Hypothesis 1 | Pioglitazone | Sitagliptin |
| BMI>30kg/m2 | 33/263 (12.5%) | 28/272 (10.3%) |
| BMI<=30kg/m2 | 17/185 (9.2%) | 16/182 (8.8%) |
| Hypothesis 2 | Sitagliptin | Canagliflozin |
| eGFR 60-90 | 17/220 (7.7%) | 12/221 (5.4%) |
| eGFR>90 | 27/234 (11.5%) | 17/246 (6.9%) |